Moderator: Jens Fiehler
Guests: Marios Psychogios, Frédéric Clarençon
Supported by WallabyPhenox
At the ESMINT TV Studio, Prof. Jens Fiehler, Prof. Marios Psychogios, and Prof. Frédéric Clarençon explore how engineering innovation translates into clinical impact — from lessons learned in distal thrombectomy trials to the landmark COATING study on HPC-coated flow diverters and single antiplatelet therapy, and the ambitious ten-year TRUST registry focusing on long-term imaging and outcome data.
They discuss the role of Pegasus in rescue stenting, the agility of a mid-sized company driving large-scale studies, and the growing importance of solid evidence since 2015. Insightful, candid, and forward-looking – “the best is yet to come.”